{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T23:53:16Z","timestamp":1773013996778,"version":"3.50.1"},"reference-count":117,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Translational Medicine"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.retram.2023.103434","type":"journal-article","created":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T07:51:42Z","timestamp":1700812302000},"page":"103434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cytogenetics in the management of B-cell acute lymphoblastic leukemia: Guidelines from the Groupe Francophone de Cytog\u00e9n\u00e9tique H\u00e9matologique (GFCH)"],"prefix":"10.1016","volume":"71","author":[{"given":"Giulia","family":"Tueur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Quessada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolien","family":"De Bie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Cuccuini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saloua","family":"Toujani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Lefebvre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Luquet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucienne","family":"Michaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7171-5930","authenticated-orcid":false,"given":"Marina","family":"Lafage-Pochitaloff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.retram.2023.103434_bib0001","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.retram.2023.103434_bib0002","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.retram.2023.103434_bib0003","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.3324\/haematol.2020.247031","article-title":"Pediatric acute lymphoblastic leukemia","volume":"105","author":"Inaba","year":"2020","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.retram.2023.103434_bib0004","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S1470-2045(19)30031-2","article-title":"Comparative features and outcomes between paediatric T-cell and B-cell acute lymphoblastic leukaemia","volume":"20","author":"Teachey","year":"2019","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.retram.2023.103434_bib0005","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13045-020-00905-2","article-title":"Evolving therapy of adult acute lymphoblastic leukemia: state-of-the-art treatment and future directions","volume":"13","author":"Samra","year":"2020","journal-title":"J Hematol OncolJ Hematol Oncol"},{"issue":"10","key":"10.1016\/j.retram.2023.103434_bib0006","first-page":"1783","article-title":"Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL)","volume":"9","author":"Bene","year":"1995","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.retram.2023.103434_bib0007","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3324\/haematol.2021.280557","article-title":"Molecular characterization and clinical outcome of B-cell precursor acute lymphoblastic leukemia with IG-MYC rearrangement","volume":"108","author":"Bomken","year":"2023","journal-title":"Haematologica"},{"issue":"16","key":"10.1016\/j.retram.2023.103434_bib0008","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1182\/blood-2017-05-783852","article-title":"Impact of cytogenetic abnormalities in adults with Ph-negative B-cell precursor acute lymphoblastic leukemia","volume":"130","author":"Lafage-Pochitaloff","year":"2017","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.retram.2023.103434_bib0009","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/s41375-021-01448-2","article-title":"Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study","volume":"36","author":"Moorman","year":"2022","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.retram.2023.103434_bib0010","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1470-2045(10)70066-8","article-title":"Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97\/99 randomised trial","volume":"11","author":"Moorman","year":"2010","journal-title":"Lancet Oncol"},{"issue":"13","key":"10.1016\/j.retram.2023.103434_bib0011","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1182\/blood-2012-06-437681","article-title":"Hyperdiploidy with 58-66 chromosomes in childhood B-acute lymphoblastic leukemia is highly curable: 58951 CLG-EORTC results","volume":"121","author":"Dastugue","year":"2013","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.retram.2023.103434_bib0012","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S2352-3026(21)00304-5","article-title":"Defining low-risk high hyperdiploidy in patients with paediatric acute lymphoblastic leukaemia: a retrospective analysis of data from the UKALL97\/99 and UKALL2003 clinical trials","volume":"8","author":"Enshaei","year":"2021","journal-title":"Lancet Haematol"},{"issue":"9","key":"10.1016\/j.retram.2023.103434_bib0013","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/s41588-022-01159-z","article-title":"The genomic landscape of pediatric acute lymphoblastic leukemia","volume":"54","author":"Brady","year":"2022","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.retram.2023.103434_bib0014","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1182\/blood-2016-10-743765","article-title":"Near-haploid and low-hypodiploid acute lymphoblastic leukemia: two distinct subtypes with consistently poor prognosis","volume":"129","author":"Safavi","year":"2017","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.retram.2023.103434_bib0015","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/ng.2532","article-title":"The genomic landscape of hypodiploid acute lymphoblastic leukemia","volume":"45","author":"Holmfeldt","year":"2013","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.retram.2023.103434_bib0016","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1158\/2643-3230.BCD-22-0154","article-title":"Adult low-hypodiploid acute lymphoblastic leukemia emerges from preleukemic TP53-mutant clonal hematopoiesis","volume":"4","author":"Kim","year":"2023","journal-title":"Blood Cancer Discov"},{"issue":"25","key":"10.1016\/j.retram.2023.103434_bib0017","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1056\/NEJMra2113347","article-title":"Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"386","author":"Fo\u00e0","year":"2022","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.retram.2023.103434_bib0018","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/sj.leu.2403324","article-title":"Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcome","volume":"18","author":"Heerema","year":"2004","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.retram.2023.103434_bib0019","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1365-2141.2003.04736.x","article-title":"Additional cytogenetic abnormalities in adults with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a study of the cancer and leukaemia Group B","volume":"124","author":"Wetzler","year":"2004","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.retram.2023.103434_bib0020","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/10428194.2017.1326596","article-title":"Frequency and prognostic significance of additional cytogenetic abnormalities to the Philadelphia chromosome in young and older adults with acute lymphoblastic leukemia","volume":"59","author":"Motll\u00f3","year":"2018","journal-title":"Leuk Lymphoma"},{"issue":"24","key":"10.1016\/j.retram.2023.103434_bib0021","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1182\/blood-2015-02-627935","article-title":"Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia","volume":"125","author":"Chalandon","year":"2015","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.retram.2023.103434_bib0022","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1002\/cncr.25978","article-title":"Prognostic significance of immunophenotypic and karyotypic features of Philadelphia positive B-lymphoblastic leukemia in the era of tyrosine kinase inhibitors","volume":"117","author":"Jaso","year":"2011","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.retram.2023.103434_bib0023","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3324\/haematol.11891","article-title":"Karyotype at diagnosis is the major prognostic factor predicting relapse-free survival for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib-combined chemotherapy","volume":"93","author":"Yanada","year":"2008","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.retram.2023.103434_bib0024","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.bbmt.2015.03.021","article-title":"Impact of additional cytogenetic abnormalities in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia undergoing allogeneic hematopoietic cell transplantation","volume":"21","author":"Aldoss","year":"2015","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.retram.2023.103434_bib0025","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/ajh.24625","article-title":"Poor outcomes associated with +der(22)t(9;22) and -9\/9p in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving chemotherapy plus a tyrosine kinase inhibitor","volume":"92","author":"Short","year":"2017","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.retram.2023.103434_bib0026","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.3324\/haematol.2020.247973","article-title":"Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913","volume":"106","author":"Chiaretti","year":"2021","journal-title":"Haematologica"},{"issue":"13","key":"10.1016\/j.retram.2023.103434_bib0027","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1182\/blood-2017-07-796862","article-title":"Genomic CDKN2A\/2B deletions in adult Ph+ ALL are adverse despite allogeneic stem cell transplantation","volume":"131","author":"Pfeifer","year":"2018","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.retram.2023.103434_bib0028","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/s41375-021-01496-8","article-title":"Genetic correlates in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with Hyper-CVAD plus dasatinib or ponatinib","volume":"36","author":"Sasaki","year":"2022","journal-title":"Leukemia"},{"issue":"20","key":"10.1016\/j.retram.2023.103434_bib0029","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1182\/blood-2016-11-749978","article-title":"Monitoring of childhood ALL using BCR-ABL1 genomic breakpoints identifies a subgroup with CML-like biology","volume":"129","author":"Hovorkova","year":"2017","journal-title":"Blood."},{"issue":"18","key":"10.1016\/j.retram.2023.103434_bib0030","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1182\/blood-2017-05-782888","article-title":"Hematopoietic stem cell involvement in BCR-ABL1-positive ALL as a potential mechanism of resistance to blinatumomab therapy","volume":"130","author":"Nagel","year":"2017","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.retram.2023.103434_bib0031","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1038\/s41375-022-01668-0","article-title":"Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease","volume":"36","author":"Zuna","year":"2022","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.retram.2023.103434_bib0032","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/s41375-023-01877-1","article-title":"The KMT2A recombinome of acute leukemias in 2023","volume":"37","author":"Meyer","year":"2023","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.retram.2023.103434_bib0033","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1200\/JCO.22.01297","article-title":"Outcomes of childhood noninfant acute lymphoblastic leukemia With 11q23\/KMT2A rearrangements in a modern therapy era: a retrospective international study","volume":"41","author":"Attarbaschi","year":"2023","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"3","key":"10.1016\/j.retram.2023.103434_bib0034","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/gcc.20082","article-title":"MLL translocations with concurrent 3\u2019 deletions: interpretation of FISH results","volume":"41","author":"Barber","year":"2004","journal-title":"Genes Chromosomes Cancer"},{"issue":"4","key":"10.1016\/j.retram.2023.103434_bib0035","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ng.3230","article-title":"The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias","volume":"47","author":"Andersson","year":"2015","journal-title":"Nat Genet"},{"issue":"23","key":"10.1016\/j.retram.2023.103434_bib0036","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1182\/bloodadvances.2021004580","article-title":"Outcomes of acute lymphoblastic leukemia with KMT2A (MLL) rearrangement: the MD Anderson experience","volume":"5","author":"Richard-Carpentier","year":"2021","journal-title":"Blood Adv"},{"issue":"17","key":"10.1016\/j.retram.2023.103434_bib0037","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1056\/NEJMoa2214171","article-title":"Blinatumomab added to chemotherapy in infant lymphoblastic leukemia","volume":"388","author":"van der Sluis","year":"2023","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.retram.2023.103434_bib0038","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/s41467-023-36370-x","article-title":"Proteasome inhibition targets the KMT2A transcriptional complex in acute lymphoblastic leukemia","volume":"14","author":"Kamens","year":"2023","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.retram.2023.103434_bib0039","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41375-022-01746-3","article-title":"Preclinical efficacy of azacitidine and venetoclax for infant KMT2A-rearranged acute lymphoblastic leukemia reveals a new therapeutic strategy","volume":"37","author":"Cheung","year":"2023","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.retram.2023.103434_bib0040","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1182\/hematology.2022000359","article-title":"Updates in infant acute lymphoblastic leukemia and the potential for targeted therapy","volume":"2022","author":"Kotecha","year":"2022","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"3","key":"10.1016\/j.retram.2023.103434_bib0041","first-page":"233","article-title":"Pre-natal origins of childhood leukemia","volume":"7","author":"Greaves","year":"2003","journal-title":"Rev Clin Exp Hematol"},{"issue":"9","key":"10.1016\/j.retram.2023.103434_bib0042","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1038\/sj.leu.2401506","article-title":"Cytogenetic abnormalities associated with the t(12;21): a collaborative study of 169 children with t(12;21)-positive acute lymphoblastic leukemia","volume":"13","author":"Raynaud","year":"1999","journal-title":"Leukemia"},{"issue":"7330","key":"10.1016\/j.retram.2023.103434_bib0043","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature09650","article-title":"Genetic variegation of clonal architecture and propagating cells in leukaemia","volume":"469","author":"Anderson","year":"2011","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.retram.2023.103434_bib0044","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1038\/leu.2013.136","article-title":"Long-term follow-up of ETV6-RUNX1 ALL reveals that NCI risk, rather than secondary genetic abnormalities, is the key risk factor","volume":"27","author":"Enshaei","year":"2013","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.retram.2023.103434_bib0045","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/bjh.17869","article-title":"Genetic characterisation of childhood B-other-acute lymphoblastic leukaemia in UK patients by fluorescence in situ hybridisation and multiplex ligation-dependent probe amplification","volume":"196","author":"Schwab","year":"2022","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.retram.2023.103434_bib0046","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood.2020010144","article-title":"Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL","volume":"138","author":"Paietta","year":"2021","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.retram.2023.103434_bib0047","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/leu.2013.317","article-title":"An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome","volume":"28","author":"Harrison","year":"2014","journal-title":"Leukemia"},{"issue":"7494","key":"10.1016\/j.retram.2023.103434_bib0048","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nature13115","article-title":"Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia","volume":"508","author":"Li","year":"2014","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.retram.2023.103434_bib0049","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/HS9.0000000000000053","article-title":"Advances in B-cell precursor acute lymphoblastic leukemia genomics","volume":"2","author":"Schwab","year":"2018","journal-title":"HemaSphere"},{"issue":"12","key":"10.1016\/j.retram.2023.103434_bib0050","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/gcc.23084","article-title":"Characterization of unusual iAMP21 B-lymphoblastic leukemia (iAMP21-ALL) from the Mayo Clinic and Children\u2019s Oncology Group","volume":"61","author":"Koleilat","year":"2022","journal-title":"Genes Chromosomes Cancer"},{"issue":"8","key":"10.1016\/j.retram.2023.103434_bib0051","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1182\/blood.2022019094","article-title":"The genomic landscape of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21","volume":"142","author":"Gao","year":"2023","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.retram.2023.103434_bib0052","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/s41375-022-01561-w","article-title":"The complex karyotype in hematological malignancies: a comprehensive overview by the Francophone Group of Hematological Cytogenetics (GFCH)","volume":"36","author":"Nguyen-Khac","year":"2022","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.retram.2023.103434_bib0053","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/ng.469","article-title":"Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia","volume":"41","author":"Mullighan","year":"2009","journal-title":"Nat Genet"},{"issue":"13","key":"10.1016\/j.retram.2023.103434_bib0054","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1182\/blood-2009-03-208397","article-title":"Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia","volume":"114","author":"Russell","year":"2009","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.retram.2023.103434_bib0055","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejmg.2016.01.006","article-title":"Constitutional abnormalities of chromosome 21 predispose to iAMP21-acute lymphoblastic leukaemia","volume":"59","author":"Harrison","year":"2016","journal-title":"Eur J Med Genet"},{"issue":"8","key":"10.1016\/j.retram.2023.103434_bib0056","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1002\/ajmg.a.62864","article-title":"B-cell acute lymphoblastic leukemia with iAMP21 in a patient with Down syndrome due to a constitutional isodicentric chromosome 21","volume":"188","author":"Verdoni","year":"2022","journal-title":"Am J Med Genet A"},{"issue":"5","key":"10.1016\/j.retram.2023.103434_bib0057","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/gcc.20431","article-title":"Molecular cytogenetic characterization of TCF3 (E2A)\/19p13.3 rearrangements in B-cell precursor acute lymphoblastic leukemia","volume":"46","author":"Barber","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"issue":"12","key":"10.1016\/j.retram.2023.103434_bib0058","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.cancergen.2012.10.004","article-title":"A novel TCF3-HLF fusion transcript in acute lymphoblastic leukemia with a t(17;19)(q22;p13)","volume":"205","author":"Panagopoulos","year":"2012","journal-title":"Cancer Genet"},{"issue":"2","key":"10.1016\/j.retram.2023.103434_bib0059","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/sj.leu.2404496","article-title":"Hypercalcemia in childhood acute lymphoblastic leukemia: frequent implication of parathyroid hormone-related peptide and E2A-HLF from translocation 17;19","volume":"21","author":"Inukai","year":"2007","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.retram.2023.103434_bib0060","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/ng.3362","article-title":"Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options","volume":"47","author":"Fischer","year":"2015","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.retram.2023.103434_bib0061","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3324\/haematol.2018.210104","article-title":"Durable remissions in TCF3-HLF positive acute lymphoblastic leukemia with blinatumomab and stem cell transplantation","volume":"104","author":"Mouttet","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.retram.2023.103434_bib0062","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.3389\/fonc.2019.01374","article-title":"B-ALL With t(5;14)(q31;q32); IGH-IL3 rearrangement and eosinophilia: a comprehensive analysis of a peculiar IGH-rearranged B-ALL","volume":"9","author":"Fournier","year":"2019","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.retram.2023.103434_bib0063","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1470-2045(08)70339-5","article-title":"A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study","volume":"10","author":"Den Boer","year":"2009","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.retram.2023.103434_bib0064","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1056\/NEJMoa0808253","article-title":"Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia","volume":"360","author":"Mullighan","year":"2009","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.retram.2023.103434_bib0065","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","article-title":"Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia","volume":"371","author":"Roberts","year":"2014","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.retram.2023.103434_bib0066","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1182\/bloodadvances.2019000163","article-title":"Clinical diagnostics and treatment strategies for Philadelphia chromosome-like acute lymphoblastic leukemia","volume":"4","author":"Harvey","year":"2020","journal-title":"Blood Adv"},{"issue":"5","key":"10.1016\/j.retram.2023.103434_bib0067","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3390\/genes12050687","article-title":"Genetic alterations and therapeutic targeting of philadelphia-like acute lymphoblastic leukemia","volume":"12","author":"Iacobucci","year":"2021","journal-title":"Genes"},{"issue":"1","key":"10.1016\/j.retram.2023.103434_bib0068","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1182\/hematology.2022000357","article-title":"Clinical screening for Ph-like ALL and the developing role of TKIs","volume":"2022","author":"Tran","year":"2022","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"5","key":"10.1016\/j.retram.2023.103434_bib0069","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/bjh.17093","article-title":"Adjuvant tyrosine kinase inhibitor therapy improves outcome for children and adolescents with acute lymphoblastic leukaemia who have an ABL-class fusion","volume":"191","author":"Moorman","year":"2020","journal-title":"Br J Haematol"},{"issue":"16","key":"10.1016\/j.retram.2023.103434_bib0070","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1182\/blood.2019001244","article-title":"Efficacy of tyrosine kinase inhibitors in Ph-like acute lymphoblastic leukemia harboring ABL-class rearrangements","volume":"134","author":"Tanasi","year":"2019","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.retram.2023.103434_bib0071","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/gcc.22439","article-title":"Characterisation of the genomic landscape of CRLF2-rearranged acute lymphoblastic leukemia","volume":"56","author":"Russell","year":"2017","journal-title":"Genes Chromosomes Cancer"},{"issue":"5","key":"10.1016\/j.retram.2023.103434_bib0072","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cancergen.2013.04.004","article-title":"Chromosomal translocations involving the IGH@ locus in B-cell precursor acute lymphoblastic leukemia: 29 new cases and a review of the literature","volume":"206","author":"Chapiro","year":"2013","journal-title":"Cancer Genet"},{"issue":"27","key":"10.1016\/j.retram.2023.103434_bib0073","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1200\/JCO.2013.48.9377","article-title":"Risk-directed treatment intensification significantly reduces the risk of relapse among children and adolescents with acute lymphoblastic leukemia and intrachromosomal amplification of chromosome 21: a comparison of the MRC ALL97\/99 and UKALL2003 trials","volume":"31","author":"Moorman","year":"2013","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"14","key":"10.1016\/j.retram.2023.103434_bib0074","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1200\/JCO.2013.51.3242","article-title":"IGH@ translocations are prevalent in teenagers and young adults with acute lymphoblastic leukemia and are associated with a poor outcome","volume":"32","author":"Russell","year":"2014","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"8","key":"10.1016\/j.retram.2023.103434_bib0075","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.3324\/haematol.2014.103820","article-title":"IGH@ translocations co-exist with other primary rearrangements in B-cell precursor acute lymphoblastic leukemia","volume":"99","author":"Jeffries","year":"2014","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.retram.2023.103434_bib0076","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/ng.3535","article-title":"Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults","volume":"48","author":"Yasuda","year":"2016","journal-title":"Nat Genet"},{"issue":"12","key":"10.1016\/j.retram.2023.103434_bib0077","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/ng.3691","article-title":"Deregulation of DUX4 and ERG in acute lymphoblastic leukemia","volume":"48","author":"Zhang","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.retram.2023.103434_bib0078","doi-asserted-by":"crossref","first-page":"11790","DOI":"10.1038\/ncomms11790","article-title":"Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia","volume":"7","author":"Lilljebj\u00f6rn","year":"2016","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.retram.2023.103434_bib0079","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/leu.2013.282","article-title":"ERG deletion is associated with CD2 and attenuates the negative impact of IKZF1 deletion in childhood acute lymphoblastic leukemia","volume":"28","author":"Zaliova","year":"2014","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.retram.2023.103434_bib0080","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/leu.2013.277","article-title":"An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions","volume":"28","author":"Clappier","year":"2014","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.retram.2023.103434_bib0081","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1182\/blood-2006-08-041012","article-title":"Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL)","volume":"109","author":"Akasaka","year":"2007","journal-title":"Blood"},{"issue":"25","key":"10.1016\/j.retram.2023.103434_bib0082","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1200\/JCO.2011.40.3907","article-title":"IGH@ translocations, CRLF2 deregulation, and microdeletions in adolescents and adults with acute lymphoblastic leukemia","volume":"30","author":"Moorman","year":"2012","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"50","key":"10.1016\/j.retram.2023.103434_bib0083","doi-asserted-by":"crossref","first-page":"11711","DOI":"10.1073\/pnas.1814397115","article-title":"Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases","volume":"115","author":"Li","year":"2018","journal-title":"Proc Natl Acad Sci USA."},{"issue":"2","key":"10.1016\/j.retram.2023.103434_bib0084","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41588-018-0315-5","article-title":"PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia","volume":"51","author":"Gu","year":"2019","journal-title":"Nat Genet"},{"issue":"12","key":"10.1016\/j.retram.2023.103434_bib0085","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1038\/leu.2015.111","article-title":"A novel recurrent EP300-ZNF384 gene fusion in B-cell precursor acute lymphoblastic leukemia","volume":"29","author":"Gocho","year":"2015","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.retram.2023.103434_bib0086","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3324\/haematol.2016.151035","article-title":"ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype","volume":"102","author":"Hirabayashi","year":"2017","journal-title":"Haematologica"},{"issue":"7727","key":"10.1016\/j.retram.2023.103434_bib0087","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41586-018-0436-0","article-title":"The genetic basis and cell of origin of mixed phenotype acute leukaemia","volume":"562","author":"Alexander","year":"2018","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.retram.2023.103434_bib0088","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3324\/haematol.2017.186320","article-title":"Clinical and molecular characteristics of MEF2D fusion-positive B-cell precursor acute lymphoblastic leukemia in childhood, including a novel translocation resulting in MEF2D-HNRNPH1 gene fusion","volume":"104","author":"Ohki","year":"2019","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.retram.2023.103434_bib0089","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41375-022-01737-4","article-title":"Clinical characteristics and outcomes of B-cell precursor ALL with MEF2D rearrangements: a retrospective study by the Ponte di Legno childhood ALL working group","volume":"37","author":"Ohki","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.retram.2023.103434_bib0090","doi-asserted-by":"crossref","first-page":"13331","DOI":"10.1038\/ncomms13331","article-title":"Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia","volume":"7","author":"Gu","year":"2016","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.retram.2023.103434_bib0091","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/leu.2013.324","article-title":"RNA-seq identifies clinically relevant fusion genes in leukemia including a novel MEF2D\/CSF1R fusion responsive to imatinib","volume":"28","author":"Lilljebj\u00f6rn","year":"2014","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.retram.2023.103434_bib0092","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1038\/s41375-021-01333-y","article-title":"Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study","volume":"35","author":"Boer","year":"2021","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.retram.2023.103434_bib0093","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3324\/haematol.2018.206961","article-title":"NUTM1 is a recurrent fusion gene partner in B-cell precursor acute lymphoblastic leukemia associated with increased expression of genes on chromosome band 10p12.31-12.2","volume":"104","author":"Hormann","year":"2019","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.retram.2023.103434_bib0094","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/leu.2008.306","article-title":"Incidence and diversity of PAX5 fusion genes in childhood acute lymphoblastic leukemia","volume":"23","author":"Nebral","year":"2009","journal-title":"Leukemia"},{"issue":"15","key":"10.1016\/j.retram.2023.103434_bib0095","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1182\/blood-2009-07-234229","article-title":"Wide diversity of PAX5 alterations in B-ALL: a Groupe Francophone de Cytogenetique Hematologique study","volume":"115","author":"Coyaud","year":"2010","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.retram.2023.103434_bib0096","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/sj.leu.2401654","article-title":"Monosomy 20 as a pointer to dicentric (9;20) in acute lymphoblastic leukemia","volume":"14","author":"Clark","year":"2000","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.retram.2023.103434_bib0097","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/gcc.22464","article-title":"ETV6\/RUNX1-like acute lymphoblastic leukemia: a novel B-cell precursor leukemia subtype associated with the CD27\/CD44 immunophenotype","volume":"56","author":"Zaliova","year":"2017","journal-title":"Genes Chromosomes Cancer"},{"issue":"3","key":"10.1016\/j.retram.2023.103434_bib0098","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/s41375-022-01806-8","article-title":"Whole genome sequencing provides comprehensive genetic testing in childhood B-cell acute lymphoblastic leukaemia","volume":"37","author":"Ryan","year":"2023","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.retram.2023.103434_bib0099","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41375-022-01799-4","article-title":"Integrative genomic analysis of childhood acute lymphoblastic leukaemia lacking a genetic biomarker in the UKALL2003 clinical trial","volume":"37","author":"Schwab","year":"2023","journal-title":"Leukemia"},{"issue":"19","key":"10.1016\/j.retram.2023.103434_bib0100","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1182\/bloodadvances.2017006734","article-title":"Intragenic amplification of PAX5: a novel subgroup in B-cell precursor acute lymphoblastic leukemia?","volume":"1","author":"Schwab","year":"2017","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.retram.2023.103434_bib0101","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/blood-2018-10-882142","article-title":"PAX5 P80R mutation identifies a novel subtype of B-cell precursor acute lymphoblastic leukemia with favorable outcome","volume":"133","author":"Passet","year":"2019","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.retram.2023.103434_bib0102","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/gcc.22882","article-title":"Frequency and prognostic impact of PAX5 p.P80R in pediatric acute lymphoblastic leukemia patients treated on an AIEOP-BFM acute lymphoblastic leukemia protocol","volume":"59","author":"Jung","year":"2020","journal-title":"Genes Chromosomes Cancer"},{"issue":"24","key":"10.1016\/j.retram.2023.103434_bib0103","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1182\/blood.2021014723","article-title":"Concurrent CDX2 cis-deregulation and UBTF::ATXN7L3 fusion define a novel high-risk subtype of B-cell ALL","volume":"139","author":"Passet","year":"2022","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.retram.2023.103434_bib0104","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1182\/blood.2022015444","article-title":"Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemia","volume":"139","author":"Kimura","year":"2022","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.retram.2023.103434_bib0105","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1182\/blood-2006-10-051912","article-title":"Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII\/Eastern Cooperative Oncology Group (ECOG) 2993 trial","volume":"109","author":"Moorman","year":"2007","journal-title":"Blood"},{"issue":"7137","key":"10.1016\/j.retram.2023.103434_bib0106","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nature05690","article-title":"Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia","volume":"446","author":"Mullighan","year":"2007","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.retram.2023.103434_bib0107","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/sj.leu.2404691","article-title":"High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression","volume":"21","author":"Kuiper","year":"2007","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.retram.2023.103434_bib0108","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1182\/blood-2014-03-562918","article-title":"A novel integrated cytogenetic and genomic classification refines risk stratification in pediatric acute lymphoblastic leukemia","volume":"124","author":"Moorman","year":"2014","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.retram.2023.103434_bib0109","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1182\/bloodadvances.2018025718","article-title":"Validation of the United Kingdom copy-number alteration classifier in 3239 children with B-cell precursor ALL","volume":"3","author":"Hamadeh","year":"2019","journal-title":"Blood Adv"},{"issue":"5","key":"10.1016\/j.retram.2023.103434_bib0110","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1182\/bloodadvances.2019001008","article-title":"The application of RNA sequencing for the diagnosis and genomic classification of pediatric acute lymphoblastic leukemia","volume":"4","author":"Brown","year":"2020","journal-title":"Blood Adv"},{"issue":"15","key":"10.1016\/j.retram.2023.103434_bib0111","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1182\/bloodadvances.2022008992","article-title":"Diagnostic utility of whole genome sequencing in adults with B-other acute lymphoblastic leukemia","volume":"7","author":"Leongamornlert","year":"2023","journal-title":"Blood Adv"},{"issue":"10","key":"10.1016\/j.retram.2023.103434_bib0112","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/gcc.22971","article-title":"Optical genome mapping, a promising alternative to gold standard cytogenetic approaches in a series of acute lymphoblastic leukemias","volume":"60","author":"Lestringant","year":"2021","journal-title":"Genes Chromosomes Cancer"},{"issue":"5","key":"10.1016\/j.retram.2023.103434_bib0113","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/ajh.26487","article-title":"Optimizing the diagnostic workflow for acute lymphoblastic leukemia by optical genome mapping","volume":"97","author":"Rack","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.retram.2023.103434_bib0114","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1038\/s41375-019-0696-1","article-title":"Recommendations for cytogenomic analysis of hematologic malignancies: comments from the Francophone Group of Hematological Cytogenetics (GFCH)","volume":"34","author":"Nguyen-Khac","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.retram.2023.103434_bib0115","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-1-61779-074-4_8","article-title":"Acute lymphoblastic leukaemia","volume":"730","author":"Schwab","year":"2011","journal-title":"Methods Mol Biol Clifton NJ"},{"issue":"17","key":"10.1016\/j.retram.2023.103434_bib0116","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.3390\/jcm10173792","article-title":"Biologic and therapeutic implications of genomic alterations in acute lymphoblastic leukemia","volume":"10","author":"Iacobucci","year":"2021","journal-title":"J Clin Med"},{"issue":"21","key":"10.1016\/j.retram.2023.103434_bib0117","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1182\/blood.2022015853","article-title":"Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia","volume":"140","author":"Duncavage","year":"2022","journal-title":"Blood"}],"container-title":["Current Research in Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318623000582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318623000582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:43:03Z","timestamp":1762821783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452318623000582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":117,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S2452318623000582"],"URL":"https:\/\/doi.org\/10.1016\/j.retram.2023.103434","relation":{},"ISSN":["2452-3186"],"issn-type":[{"value":"2452-3186","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytogenetics in the management of B-cell acute lymphoblastic leukemia: Guidelines from the Groupe Francophone de Cytog\u00e9n\u00e9tique H\u00e9matologique (GFCH)","name":"articletitle","label":"Article Title"},{"value":"Current Research in Translational Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.retram.2023.103434","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"103434"}}